EUVIMEDEUVIMED entdecken
Crossref

Questionnaire on the surgical indications for intrahepatic cholangiocarcinoma administered to Japanese board‐certified expert hepatobiliary and pancreatic surgeons and instructors

Shintaro Kuroda iD, Tsuyoshi Kobayashi iD, Etsuro Hatano iD, Shoji Kubo, Itaru Endo iD, Hideki Ohdan, JSHBPS2024‐ICC survey consortium

Journal of Hepato-Biliary-Pancreatic Sciences · 2025

DOI: 10.1002/jhbp.12108 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Hepato-Biliary-Pancreatic Sciences, 2025. Verfasst von Shintaro Kuroda und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterological Surgery, Hiroshima University Hospital, Hiroshima, Japan. Hauptthemen laut MEDLINE: Bile Duct Neoplasms, Cholangiocarcinoma, Practice Patterns, Physicians'. Die Arbeit nennt 31 Literaturangaben. Gefördert von: JSPS KAKENHI.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Treatment of intrahepatic cholangiocarcinoma (ICC) remains challenging owing to the lack of clear guidelines on surgical resection. The 2021 ICC guidelines have not fully resolved the ongoing debate between surgical and nonsurgical treatment options. This study aimed to identify trends and issues in ICC treatment strategies in the clinical field by surveying the attitudes of hepatobiliary and pancreatic (HBP) surgeons.

Methods

A survey was conducted among 235 board‐certified HBP surgeons affiliated with the Japanese Society of Hepato‐Biliary‐Pancreatic Surgery. This survey explored the perspectives on tumor conditions that define resectable, borderline resectable, and unresectable diseases, focusing on tumor size, number, and vascular invasion.

Results

Notable variability was observed in the criteria for oncological resectability. While 42.1% of the respondents considered a maximum tumor diameter of 5 cm as resectable, 37.5% indicated no size limit for resectability. Opinions regarding the resectability of tumors with lymph node involvement and vascular invasion vary widely, highlighting the need for standardized criteria.

Conclusion

This survey revealed diverse approaches for defining resectability in ICC, emphasizing the necessity for more precise guidelines. Further research and expert consensus are required to establish standardized criteria that can guide clinical decision‐making and improve patient outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bile Duct NeoplasmsCholangiocarcinomaPractice Patterns, Physicians'FemaleHumansMaleHepatectomyJapanSurgeonsSurveys and Questionnaires

Stichwörter der Autor:innen

intrahepatic cholangiocarcinomaoncological criteriaresectabilitysurgerysurvey

Autor:innen und Institutionen

  • Department of Gastroenterological Surgery, Hiroshima University Hospital, Hiroshima, Japan.
  • Division of Hepato-Biliary-Pancreatic Surgery and Transplantation, Department of Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Department of Education, Shitennoji University, Osaka, Japan.
  • Department of Hepato-Biliary-Pancreatic Surgery, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan.
  • Department of Gastroenterological Surgery, Yokohama City University Graduate School of Medicine, Yokohama, Japan.

ORCID-Profile: Shintaro Kuroda, Tsuyoshi Kobayashi, Etsuro Hatano, Itaru Endo

Förderung

  • JSPS KAKENHI

Zitieren

APA

Kuroda, S., Kobayashi, T., Hatano, E., Kubo, S., Endo, I., Ohdan, H., & JSHBPS2024‐ICC survey consortium (2025). Questionnaire on the surgical indications for intrahepatic cholangiocarcinoma administered to Japanese board‐certified expert hepatobiliary and pancreatic surgeons and instructors. Journal of Hepato-Biliary-Pancreatic Sciences. https://doi.org/10.1002/jhbp.12108

Vancouver

Kuroda S, Kobayashi T, Hatano E, Kubo S, Endo I, Ohdan H, et al. Questionnaire on the surgical indications for intrahepatic cholangiocarcinoma administered to Japanese board‐certified expert hepatobiliary and pancreatic surgeons and instructors. Journal of Hepato-Biliary-Pancreatic Sciences. 2025. doi:10.1002/jhbp.12108

BibTeX
@article{Kuroda2025,
  author = {Kuroda, Shintaro and Kobayashi, Tsuyoshi and Hatano, Etsuro and Kubo, Shoji and Endo, Itaru and Ohdan, Hideki and JSHBPS2024‐ICC survey consortium, JSHBPS2024‐ICC survey consortium},
  title = {Questionnaire on the surgical indications for intrahepatic cholangiocarcinoma administered to Japanese board‐certified expert hepatobiliary and pancreatic surgeons and instructors},
  journal = {Journal of Hepato-Biliary-Pancreatic Sciences},
  year = {2025},
  doi = {10.1002/jhbp.12108}
}
Kostenlos starten →